Research around the global is focusing on a faster, more precise approach in diagnostics.
A new technology from Nanomix is targeting fast detection to expedite patient treatment and improve outcomes.
The deal will further cement the company’s competitive advantage in providing ‘comprehensive musculoskeletal healthcare’.
Medtech manufacturers are taking advantage of this global opportunity.
There are concerns over the accuracy of direct-to-consumer tests.
Technology that quickly and accurately diagnoses cancer will be in high demand in the coming years.
The increase in communicable diseases is elevating competition in the device arena.
Contributing factors include a change in lifestyle, an increase in wealth, and chronic infections in rural regions.
The deal will help Roche develop combination therapies and identify cancer patients more accurately.
There is a pressure on medical device product development teams to come to terms with new types of users, environments, distribution and sales models as opposed to more traditional scenarios of device use and sale, says ide’s Richard Sokolov.